Down-regulation of the vascular endothelial growth factor(VEGF) by a small interfering RNA targeting VEGF in the nasopharyngeal carcinoma cell line(CNE-2Z)
Xiong Siqi
Abstract
Xiong Siqi
Abstract
Objective To investigate the inhibitory effect of a small interfering RNA targeting the vascular endothelial growth factor(VEGF) in the nasopharyngeal carcinoma cell line(CNE-2Z) in vitro,and to explore a new approach to gene-therapy for retinal revascularization.Methods Nasopharyngeal carcinoma cells were cultured in vitro and divided into a normoxia group(20%) and a hypoxia group(5%).After VEGF siRNA was transfected into CNE-2Z by Lipofectamine 2000,VEGF expression was tested with immunohistochemical staining and ELISA.Results VEGF_(165) and VEGF_(121) proteins were expressed in the cytoplasm of CNE-2Z cells under normoxia(brown particle) and the expression increased under hypoxia.Under normoxia,the expressions of secreting VEGF_(165) shown by ELISA in the non-transfection group,the pSilencer2.1-U6 hygro transfection group and the VEGF siRNA transfection group were 419.72 pg/ml,410.61 pg/ml and 320.76 pg/ml,respectively.Under hypoxia,the expressions of secreting VEGF_(165) protein in above three groups were 805.61 pg/ml,798.81 pg/ml and 496.56 pg/ml,respectively.VEGF siRNA down-regulated the expression of VEGF_(165).Conclusion VEGF specific siRNA can effectively down-regulate the expression of VEGF protein in CNE-2Z cells in vitro,thus it may be a potential therapeutic approach in retinal vascularization.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To investigate the inhibitory effect of a small interfering RNA targeting the vascular endothelial growth factor(VEGF) in the nasopharyngeal carcinoma cell line(CNE-2Z) in vitro,and to explore a new approach to gene-therapy for retinal revascularization.Methods Nasopharyngeal carcinoma cells were cultured in vitro and divided into a normoxia group(20%) and a hypoxia group(5%).After VEGF siRNA was transfected into CNE-2Z by Lipofectamine 2000,VEGF expression was tested with immunohistochemical staining and ELISA.Results VEGF_(165) and VEGF_(121) proteins were expressed in the cytoplasm of CNE-2Z cells under normoxia(brown particle) and the expression increased under hypoxia.Under normoxia,the expressions of secreting VEGF_(165) shown by ELISA in the non-transfection group,the pSilencer2.1-U6 hygro transfection group and the VEGF siRNA transfection group were 419.72 pg/ml,410.61 pg/ml and 320.76 pg/ml,respectively.Under hypoxia,the expressions of secreting VEGF_(165) protein in above three groups were 805.61 pg/ml,798.81 pg/ml and 496.56 pg/ml,respectively.VEGF siRNA down-regulated the expression of VEGF_(165).Conclusion VEGF specific siRNA can effectively down-regulate the expression of VEGF protein in CNE-2Z cells in vitro,thus it may be a potential therapeutic approach in retinal vascularization.
Key concepts: Nasopharyngeal carcinoma, Vascular endothelial growth factor, Lipofectamine, Transfection, Small interfering RNA, Cell culture, Molecular biology, Vascular endothelial growth factor A